I'd prefer the $100/share buyout myself.
Bahahahahaha! Sorry I tried to keep a straight face saying that.
I don't think we'll ever see a dividend here (unless it's a small, one-timer to flush out those nasty naked shorts). With the breadth of our pipeline I think there will always be better uses for any cash we have. Imbruvica was running 13 phase 3 trials when it was acquired and that was a tightly focused blood cancer drug. Between B and P we're looking at potential Humira-like versatility.
Now, if we get to the point where we're running dozens of phase 3 trials and still overflowing with cash...well, most of us won't care about a dividend at that point.
Go IPIX!
Bahahahahaha! Sorry I tried to keep a straight face saying that.
I don't think we'll ever see a dividend here (unless it's a small, one-timer to flush out those nasty naked shorts). With the breadth of our pipeline I think there will always be better uses for any cash we have. Imbruvica was running 13 phase 3 trials when it was acquired and that was a tightly focused blood cancer drug. Between B and P we're looking at potential Humira-like versatility.
Now, if we get to the point where we're running dozens of phase 3 trials and still overflowing with cash...well, most of us won't care about a dividend at that point.
Go IPIX!
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.